CLINICAL_TRIALS
trial_result
· 2022-04-27
Clinical Trial Update: A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia [Phase 3]
Summary
Phase 3 trial assessing PF-06462700 in Japanese participants with aplastic anemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Aplastic Anemia | Phase 3 | Status: COMPLETED | Results posted: 2022-04-27